Pediatric Neurology
Volume 26, Issue 1 , Pages 30-36 , January 2002

Nonmuscular involvement in merosin-negative congenital muscular dystrophy

  • H.Jacobus Gilhuis, MD

      Affiliations

    • Neuromuscular Centre Nijmegen, Department of Paediatric Neurology, University Medical Centre St Radboud, Nijmegen, The Netherlands
    • ,
  • Hans J ten Donkelaar, MD, PhD

      Affiliations

    • Neuromuscular Centre Nijmegen, Department of Neurology and Clinical Neurophysiology, University Medical Centre St Radboud, Nijmegen, The Netherlands
    • ,
  • Ronald B Tanke, MD

      Affiliations

    • Children’s Heart Centre, University Medical Centre St Radboud, Nijmegen, The Netherlands
    • ,
  • Dick M Vingerhoets, MD

      Affiliations

    • Neuromuscular Centre Nijmegen, Department of Neurology and Clinical Neurophysiology, University Medical Centre St Radboud, Nijmegen, The Netherlands
    • ,
  • Machiel J Zwarts, MD, PhD

      Affiliations

    • Neuromuscular Centre Nijmegen, Department of Neurology and Clinical Neurophysiology, University Medical Centre St Radboud, Nijmegen, The Netherlands
    • ,
  • Aad Verrips, MD, PhD

      Affiliations

    • Corresponding Author InformationCommunications should be addressed to: Dr. Verrips; Department of Paediatric Neurology, University Medical Centre St Radboud, Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
    • Neuromuscular Centre Nijmegen, Department of Paediatric Neurology, University Medical Centre St Radboud, Nijmegen, The Netherlands
    • ,
  • Fons J.M Gabreëls, MD, PhD

      Affiliations

    • Neuromuscular Centre Nijmegen, Department of Paediatric Neurology, University Medical Centre St Radboud, Nijmegen, The Netherlands

Received 8 May 2001 ,Accepted 9 July 2001.

References 

  1. Dubowitz V. 22nd ENMC sponsored workshop on congenital muscular dystrophy held in Baarn, The Netherlands, 14–16 May 1993. Neuromusc Disord. 1994;4:75–81
  2. Tomé FM, Evangelista T, Leclerc A, et al.  Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III. 1997;317:351–357
  3. Hillaire D, Leclerc A, Fauré S, et al.  Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet. 1994;3:1657–1661
  4. Leivo I, Engvall E. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad Sci USA. 1988;85:1544–1548
  5. Villanova M, Malandrini A, Toti P, et al.  Localization of merosin in the normal human brain (Implications for congenital muscular dystrophy with merosin deficiency). J Submicrosc Cytol Pathol. 1996;28:1–4
  6. Vuolteenaho R, Nissinen M, Sainio K, et al.  Human laminin M chain (merosin) (Complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues). J Cell Biol. 1994;124:381–394
  7. Fardeau M, Tome M, Hebing-Leclerc A, et al.  Congenital muscular dystrophy with merosin deficiency (Clinical, histopathological, immunocytochemical and genetic analysis). Rev Neurol. 1996;152:11–19
  8. Philpot J, Sewry C, Pennock J, Dubowitz V. Clinical phenotype in congenital muscular dystrophy (Correlation with expression of merosin in skeletal muscle). Neuromusc Disord. 1995;5:301–305
  9. Mercuri E, Pennock J, Goodwin F, et al.  Sequential study of central and peripheral nervous system involvement in an infant with merosin-deficient congenital muscular dystrophy. Neuromusc Disord. 1996;6:425–429
  10. Shorer Z, Philpot J, Muntoni F, Sewry C, Dubowitz V. Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy. J Child Neurol. 1995;10:472–475
  11. Spyrou N, Philpot J, Foale R, Camici PG, Muntoni F. Evidence of left ventricular dysfunction in children with merosin-deficient congenital muscular dystrophy. Am Heart J. 1988;136:474–476
  12. Sunada Y, Edgar TS, Lotz BP, Rust RS, Campell KP. Merosin-negative muscular dystrophy associated with extensive brain abnormalities. Neurology. 1995;45:2084–2089
  13. Taratuto AL, Lubieniecki F, Diaz D, et al.  Merosin-deficient congenital muscular dystrophy associated with abnormal cerebral cortical gyration (An autopsy study). Neuromusc Disord. 1999;9:86–94
  14. Lamers KJB, Wevers RA. Liquor diagnostiek (Chemische en klinische aspecten). Tijdschr NVKC. 1992;17:110–123
  15. Sobotka-Plojhar MA. Patients and methods. In:  Rohmer J,  Veerman AJP editor. Antracycline cardiotoxicity in children. An echocardiographic study. Amsterdam: VU-University Press; 1991;p. 17–25
  16. Parano E, Uncine A, De Vivo DC, Lovelace RE. Electrophysiologic correlates of peripheral nervous system maturation in fancy and childhood. J Child Neurol. 1993;8:336–338
  17. Caro PA, Scavina M, Hoffman E, Pegoraro E, Marks HG. MR imaging findings in children with merosin-deficient congenital muscular dystrophy. Am J Neuroradiol. 1999;20:324–326
  18. Trevisan CP, Martinello F, Feruzza E, Fanin M, Chevally M, Tome FM. Brain alterations in the classical form of congenital muscular dystrophy (Clinical and neuroimaging follow-up of 12 cases and correlation with the expression of merosin in muscle). Childs Nerv Syst. 1996;12:604–610
  19. Villanova M, Sewry C, Maladrini A, et al.  Immunolocalization of several laminin chains in the normal human central and peripheral nervous system. J Submicrosc Cytol Pathol. 1997;29:409–413
  20. Villanova M, Malandrini A, Sabatelli P, et al.  Localization of laminin α2 chain in normal human central nervous system (An immunofluorescence and ultrastructural study). Acta Neuropathol. 1997;94:567–571
  21. Huey PE, Marcell T, Owens GC, Etienne J, Eckel RH. Lipoprotein lipase is expressed in cultured Schwann cells and functions in lipid synthesis and utilization. J Lipid Res. 1998;39:2135–2142
  22. Saxena U, Klein MG, Goldberg IJ. Metabolism of endothelial cell-bound lipoprotein lipase. Evidence for heparan sulfate proteoglycan-mediated internalization and recycling. J Biol Chem. 1990;265:12880–12886
  23. Dobyns WB, Pagon RA, Armstrong D, et al.  Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet. 1989;32:195–210
  24. Takada K, Nakamura H, Tanaka J. Cortical dysplasia in congenital muscular dystrophy with central system involvement (Fukuyama type). J Neuropathol Exp Neurol. 1984;43:395–407
  25. Vallane L, Pihko H, Katevuo K, Kartunnen P, Somer H, Santavuori P. MRI of brain in muscle-eye-brain (MEB) disease. Neuroradiology. 1994;36:473–476
  26. Calof AL, Lander AD. Relationship between neuronal migration and cell-substratum adhesion (Laminin and merosin promote olfactory neuronal migration but are anti-adhesive). J Cell Biol. 1991;115:779–794
  27. Kamiguchi H, Hlavin ML, Yamasaki M, Lemmon V. Adhesion molecules and inherited diseases of the human nervous system. Annu Rev Neurosci. 1998;21:97–125
  28. Payne HR, Hemperly JJ, Lemmon V. N-Cadherin expression and function in cultured oligodendrocytes. Dev Brain Res. 1996;97:9–15
  29. van der Knaap MS, Smit LME, Barth PG, et al.  Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. Ann Neurol. 1997;42:50–59
  30. Philpot J, Cowan F, Pennock J, et al.  Merosin-deficient congenital muscular dystrophy (The spectrum of brain involvement on magnetic resonance imaging). Neuromusc Disord. 1999;9:81–85
  31. Pini A, Merlini L, Tome FMS, Chevallay M, Gobbi G. Merosin-negative congenital muscular dystrophy, occipital epilepsy with periodic spasms and focal dysplasia. Report of three Italian cases in two families. Brain Dev. 1996;18:316–322
  32. Cohn RD, Herrmann R, Sorokin L, Wewer UM, Voit T. Laminin α2 chain-deficient congenital muscular dystrophy. Variable epitope expression in severe and mild cases. Neurology. 1998;51:94–100
  33. Leyten QH, Gabreëls FJM, Renier WO, et al.  White matter abnormalities in congenital muscular dystrophy. J Neurol Sci. 1995;129:162–169
  34. Pegoraro E, Marks H, Garcia CA, et al.  Laminin α2 muscular dystrophy. Genotype/phenotype studies of 22 patients. Neurology. 1998;51:101–110
  35. Klietsch R, Ervasti JM, Arnold W, Campbell KP, Jorgensen AO. Dystrophin-glycoprotein complex and laminin colocalize to the sarcolemma and transverse tubules of cardiac muscles. Circ Res. 1993;72:349–360
  36. Rash SM, Shiota T, Sahn DJ, Pillers DM. Identification of hypertrophic cardiomyopathy in a congenital muscular dystrophy (cmd) mouse model. [Abstract] Am J Human Genet. 1997;61:A260
  37. Webster HF, Favilla JT. Development of peripheral nerve fibers. In: 2nd ed..  Dyck PJ,  Thomas PK,  Lambert EH,  Bunge R editor. Peripheral neuropathy. vol 1:Philadelphia: WB Saunders; 1998;p. 329–359
  38. Malandrini A, Villanova M, Sabatelli P, et al.  Localization of laminin α2 chain in normal human skeletal muscle and peripheral nerve (An ultrastructural immunolabeling study). Acta Neuropathol. 1997;93:166–172
  39. Anton ES, Sandrock AW, Matthew WD. Merosin promotes neurite growth and Schwann cell migration in vitro and nerve regeneration in vivo (Evidence using an antibody to merosin, ARM-1). Dev Biol. 1994;164:133–146
  40. Engvall E, Earwicker D, Day A, Muir D, Manthorpe M, Paulsson M. Merosin promotes cell attachment and neurite outgrowth and is a component of the neurite-promoting factor of RN22 schwannoma cells. Exp Cell Res. 1992;198:115–123
  41. Jaakkola S, Savunen O, Halme T, Uitto J, Peltonen J. Basement membranes during development of human nerve (Schwann cells and perineurial cells display marked changes in their expresson profiles for laminin sub-units and β1 and β4 integrins). J Neurocytol. 1993;22:215–230
  42. Arahata K, Hayashi YK, Koga R, et al.  Laminin in animal models for muscular dystrophy. Proc Japan Acad. 1993;69:259–264
  43. Bradley WG, Jenkison M. Neural abnormalities in the dystrophic mouse. J Neural Sci. 1975;25:249–255
  44. Sunada Y, Bernier SM, Kozak CA, Yamada Y, Campbell KP. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem. 1994;269:13729–13732
  45. Xu H, Christmas P, Wu XR, Wever UM, Engvall E. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci USA. 1994;91:5572–5576

PII: S0887-8994(01)00352-6

Pediatric Neurology
Volume 26, Issue 1 , Pages 30-36 , January 2002

Article Tools

* Image Usage & Resolution